|
|
| MRD / Regn No. |
: 20160000941 |
Date |
: 23/07/2026 |
| Patient Name |
: Vijayalakshmi Srinath |
Age & Gender |
: 72 Yrs. / Female |
| Contact No. |
: 9962593312 |
UHID |
: |
| Ht / Wt / BMI |
: |
BP S / BP D |
: |
| Allergies |
: NKA |
Referred By |
: |
| |
|
| Problem
List |
: |
HYPOTHYROIDISM, UNSPECIFIED (01/Jan/2011) | OSTEOPOROSIS (01/Jan/2013) | TYPE 2 DM (01/Jan/2012) | A2G2 DKD (02/Sep/2024) | |
|
Subjective |
: |
NO NEW COMPLAINTS |
|
Objective |
: |
NONE |
|
Analysis |
: |
ESTABLISHED OSTEOPOROSIS,HYPOTHYROIDISM,A2G2 DKD,T2DM IMPROVED CONTROL,MILD WORSENING OF BMD NO SIGNIFICANT,RECURRENT FRACTURES |
|
Plan |
: |
CONTINUE CURRENT MEDICATIONS,SEE ME IN 3 MONTHS WITH TESTING,CONSIDER TERIPERATIDE NEXT VISIT |
|
| Salient Investigations |
: |
NT PROBNP : 94.6 pg/mL | GLYCOSYLATED HEMOGLOBIN (HBA1C): 6.70 % | FREE T3: 2.3 ng/dL | FREE T4 : 1.38 ng/dL | TSH : 1.21 mIU/L | TOTAL COUNT WBC: 5000 Cells/cmm | HEMOGLOBIN: 13.9 g/dL | PCV: 41.7 % | PLATELETS: 367 thou cells/ ul | RBC COUNT: 4.63 million/ul | MCV: 99.5 fl | MCH: 28.1 pg | MCHC: 28.3 gm % | NEUTROPHILS: 49 % | LYMPHOCYTES: 45 % | MONOCYTES: 03 % | EOSINOPHILS: 03 % | BASOPHILS: 00 % | TOTAL BILIRUBIN: 0.63 mg/dL | DIRECT BILIRUBIN: 0.24 mg/dl | INDIRECT BILIRUBIN: 0.39 | SGPT (ALT): 14 IU/L | SGOT (AST): 17 U/L | GAMMA GLUTAMYL TRANSFERASE (GGT): 7.15 U/L | ALKALINE PHOSPHOTASE: 44 IU/L | TOTAL PROTEIN: 5.45 g/dl | ALBUMIN (SERUM): 4.15 g/dL | GLOBULIN: 1.3 g/dl | A\G RATIO: 3.2 g/dl | TOTAL CHOLESTEROL: 208 mg/dl | TGL TRIGLYCERIDE: 85 mg/dL | HDL HIGH DENSITY LIPOPROTEIN: 52 mg/dL | LDL LOW DENSITY LIPOPROTEIN: 138 mg/dL | VLDL: 17.2 mg/dl | TOTAL CHO/HDL RATIO: 4.0 | FASTING PLASMA GLUCOSE (FPG): 95 mg/dL | POST PRANDIAL GLUCOSE (2HPP): 104 mg/dL | BUN BLOOD UREA NITROGEN: 29 mg/dL | CREATININE: 0.90 mg/dL | MICROALBUMIN CREATININE RATIO: 264 mcg/mg | FUNDUS GLAUCOMA: NDR | FUNDUS MACULAR DEGENERATION: AMD | FUNDUS PHOTOGRAPH: AND | OCULAR PRESSURE LEFT: 0.3 mmHg | OCULAR PRESSURE R: 0.4 mm HG | FIB4: 0.89 | EGFR EGLOMERULAR FILTRATION RATE: 65.90 mL/min/1.73m2 | FIB4: 0.89 | EGFR EGLOMERULAR FILTRATION RATE: 65.90 mL/min/1.73m2 | FIB4: 0.89 | EGFR EGLOMERULAR FILTRATION RATE: 65.90 mL/min/1.73m2 | FIB4: 0.89 | EGFR EGLOMERULAR FILTRATION RATE: 65.90 mL/min/1.73m2 | RA FACTOR: <10 IU/mL | |
|
S# |
Generic (Trade) Name |
Route |
Dosage |
Usage |
Duration |
|
1 |
ROSUVASTATIN 10 MG
CRESTOR 10 MG |
PO |
0-0-1 |
AT BEDTIME
|
TILL NEXT VISIT |
| MAY | |
|
2 |
CHOLECALCIFEROL 2000 IU
D RISE 2000 IU |
PO |
0-0-1 |
AT BEDTIME
|
TILL NEXT VISIT |
| TAKE AT BEDTIME | |
|
3 |
THYROXINE 88 MCG
THYRONORM 88 MCG |
PO |
1-0-0 |
EMPTY STOMACH
|
TILL NEXT VISIT |
| MUST BE TAKEN ON AN EMPTY STOMACH. COFFEE TEA OR B... | |
|
4 |
CALCIUM CARBONATE 1250 MG VITAMIN D3 250 IU
SHELCAL 500 MG |
PO |
0-0-1 |
AT BEDTIME
|
TILL NEXT VISIT |
| CALCIUM MAY CAUSE CONSTIPATION | |
|
5 |
DAPAGLIFLOZIN METFORMIN 10 /1000 MG
XIG DUO 10 /1000 MG |
PO |
1-0-0 |
BEFORE FOOD
|
TILL NEXT VISIT |
| COMBINATION OF METFORMIN AND DAPAGLIFLOZIN MAY CAU... | |
|
6 |
TELMISARTAN 40 MG
ERITEL 40 MG |
|
0-0-1 |
AT BEDTIME
|
TILL NEXT VISIT |
| MAY CAUSE HIGH POTASSIUM | |
|
| |
|
|
|
| Refill :
0 / Substitution: |
|
|
| Education |
: |
| Next Visit |
: 21/Oct/2026 |
| Tests Suggested For Next Visit |
: + DEXA SPINE L HIP,FREE T4 TSH FBS 2HPP |
| |
|
| |
|
|
